1193 related articles for article (PubMed ID: 31210339)
1. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Inhibits TLR4/NF-κB Activation and Reduces Acute Kidney Injury after Orthotopic Autologous Liver Transplantation in Rats.
Yao H; Chi X; Jin Y; Wang Y; Huang P; Wu S; Xia Z; Cai J
Sci Rep; 2015 Nov; 5():16849. PubMed ID: 26585410
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
8. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway.
Song J; Fan HJ; Li H; Ding H; Lv Q; Hou SK
Eur J Pharmacol; 2016 Feb; 772():108-14. PubMed ID: 26698392
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
10. [Study on the anti-sepsis mechanism of ursolic acid by targeting myeloid differentiation protein-2].
Chen G; Liu C; Zhang M; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 May; 35(5):476-481. PubMed ID: 37308226
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
Qiu R; Yao W; Ji H; Yuan D; Gao X; Sha W; Wang F; Huang P; Hei Z
Life Sci; 2018 Jul; 204():1-8. PubMed ID: 29733849
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.
Liu Y; Yu Y; Zhang J; Wang C
Life Sci; 2019 Dec; 239():116868. PubMed ID: 31682847
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of dexmedetomidine against renal injury in diabetic nephropathy rats through inhibiting NF-κB pathway.
Liu YT; Liu W; Wan ZH; Wang XQ; Gu FX
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11865-11870. PubMed ID: 33275257
[TBL] [Abstract][Full Text] [Related]
18. [β1 receptor blocker decreases the myocardial inflammation in the sepsis adult rats through inhibition of TLR4/NF-ΚB signaling pathway].
Liu X; Wen M; Li X; Chen L; Zeng J; Deng Y; Zeng H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):193-197. PubMed ID: 30827308
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of Kukoamine B on the inflammatory response of small intestine in lipopolysaccharide-induced septic mice and its potential mechanisms].
Lyu W; Qin W; Zhang J; Shen W; Wang X; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):121-6. PubMed ID: 25665611
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine inhibits the lipopolysaccharide-stimulated inflammatory response in microglia through the pathway involving TLR4 and NF-κB.
Zhou XY; Liu J; Xu ZP; Fu Q; Wang PQ; Zhang H
Kaohsiung J Med Sci; 2019 Dec; 35(12):750-756. PubMed ID: 31419076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
